Transcranial infrared laser therapy improves clinical eating scores after embolic strokes in rabbits

Stroke

Volumn 35, Issue 8, 2004, Pages 1985-1988

  Lapchak, Paul A ^a,b,c   Wei, Jiandong ^b,c   Zivin, Justin A ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Clinical trials; Embolism; Laser; Neuroprotection; Stroke, acute; Stroke, ischemic

Indexed keywords

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR DISORDER; CONTROLLED STUDY; DOSE RESPONSE; EXPERIMENTAL MODEL; INFRARED RADIATION; LOW LEVEL LASER THERAPY; MALE; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; OUTCOMES RESEARCH; PARAMETER; PHOTON; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RABBIT; SCORING SYSTEM; STROKE; TRANSCRANIAL INFRARED LASER THERAPY;

ANIMALS; BEHAVIOR, ANIMAL; BLOOD GLUCOSE; BODY TEMPERATURE; CEREBROVASCULAR ACCIDENT; DISEASE MODELS, ANIMAL; INTRACRANIAL EMBOLISM; LASER THERAPY, LOW-LEVEL; MALE; RABBITS;

EID: 3242764671     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000131808.69640.b7     Document Type: Article

References (16)

1. Backman C, Friden J, Widmark A. Blood flow in chronic Achilles tendinosis. Radioactive microsphere study in rabbits. Acta Orthop Scand. 1991;62:386-387.
2. Pillar N, Thelander A. Treating chronic post-mastectomy lymphoedema with low level laser therapy: a cost effective strategy to reduce severity and improve the quality of life. Laser Ther. 1995;7:158-163.
3. Mirsky N, Krispel Y, Shoshany Y, Maltz L, Oron U. Promotion of angiogenesis by low energy laser irradiation. Antioxid Redox Signal. 2002;4:785-790.
4. Leung MC, Lo SC, Siu FK, So KF. Treatment of experimentally induced transient cerebral ischemia with low energy laser inhibits nitric oxide synthase activity and up-regulates the expression of transforming growth factor-beta 1. Lasers Surg Med. 2002;31:283-288.
5. Ad N, Oron U. Impact of low level laser irradiation on infarct size in the rat following myocardial infarction. Int J Cardiol. 2001;80:109-116.
6. Yaakobi T, Shoshany Y, Levkovitz S, Rubin O, Ben Haim SA, Oron U. Long-term effect of low energy laser irradiation on infarction and reperfusion injury in the rat heart. J Appl Physiol. 2001;90:2411-2419.
7. Shefer G, Barash I, Oron U, Halevy O. Low-energy laser irradiation enhances de novo protein synthesis via its effects on translation-regulatory proteins in skeletal muscle myoblasts. Biochim Biophys Acta. 2003;1593:131-139.
8. Oron U, Yaakobi T, Oron A, Mordechovitz D, Shofti R, Hayam G, Dror U, Gepstein L, Wolf T, Haudenschild C, Haim SB. Low-energy laser irradiation reduces formation of scar tissue after myocardial infarction in rats and dogs. Circulation. 2001;103:296-301.
9. Lapchak PA, Araujo DM, Song D, Wei J, Zivin JA. Neuroprotective effects of the spin trap agent disodium-[(tert- butylimino)methyl]benzene-1,3- disulfonate N-oxide (generic NXY-059) in a rabbit small clot embolic stroke model: combination studies with the thrombolytic tissue plasminogen activator. Stroke. 2002;33:1411-1415.
10. Lapchak PA, Araujo DM, Zivin JA. Comparison of Tenecteplase with Alteplase on clinical rating scores following small clot embolic strokes in rabbits. Exper Neurol. 2004;185:154-159.
11. Lapchak PA, Zivin JA. Ebselen, a seleno-organic antioxidant, is neuroprotective after embolic strokes in rabbits: synergism with low-dose tissue plasminogen activator. Stroke. 2003;34:2013-2018.
12. Lapchak PA, Araujo DM, Pakola S, Song D, Wei J, Zivin JA. Microplasmin: a novel thrombolytic that improves behavioral outcome after embolic strokes in rabbits. Stroke. 2002;33:2279-2284.
13. Oron U, Yaakobi T, Oron A, Hayam G, Gepstein L, Rubin O, Wolf T, Ben Haim S. Attenuation of infarct size in rats and dogs after myocardial infarction by low-energy laser irradiation. Lasers Surg Med. 2001;28:204-211.
14. Lapchak PA, Araujo DM, Song D, Wei J, Purdy R, Zivin JA. Effects of the spin trap agent disodium-[(tert-butylimino)methyl]benzene-1,3-disulfonate N-oxide (generic NXY-059) on intracerebral hemorrhage in a rabbit large clot embolic stroke model: combination studies with the thrombolytic tissue plasminogen activator. Stroke. 2002;33:1665-1670.
15. Zivin, JA, Lyden PD, DeGirolami U, Kochhar A, Mazzarella V, Hemenway CC, Johnston P. Tissue plasminogen activator. Reduction of neurologic damage after experimental embolic stroke. Arch Neurol. 1988;45:387-391.
16. Zivin JA, Fisher M, DeGirolami U, Hemenway CC, Stashak JA. Tissue plasminogen activator reduces neurological damage after cerebral embolism. Science. 1985;230:1289-1292.